COVID-19 Clinical Trials in Los Angeles

Showing 41-60 of 77 trials

Increasing Vaccine Uptake in Underresourced Public Housing Areas

NCT04779138

This proposal seeks to enhance uptake and completion of COVID-19 vaccination among African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to provide education at multiple levels and implement innovate strategies to engage this population in the uptake of COVID-19 vaccination.

CoronavirusVaccine Refusal

Charles Drew University of Medicine and Science462 participantsStarted Sep 2021

Los Angeles, California, United States

TERMINATEDPHASE3< 1 mile

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780541

This study looks at the safety and effectiveness of PF-07304814 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either PF-07304814 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H6.

COVID-19

National Institute of Allergy and Infectious Diseases (NIAID)58 participantsStarted Sep 2021

Chula Vista, California, United States • Los Angeles, California, United States • Mather, California, United States +37 more locations

Increasing Vaccine Uptake in Underresourced Public Housing Areas

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

COVID-19 Trials in Other Cities

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Bucillamine in Treatment of Patients With COVID-19

Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals

Bioaerosol Sampling Device (BSD) Clinical Study

Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

Butterfly - Clinical Performance Study

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults

Study of Sargramostim in Patients With COVID-19

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Sargramostim Use in COVID-19 to Recover Patient Health

Investigating Immune Escape by SARS-CoV-2 Variants

Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

Other Conditions in Los Angeles